Clinical and economic impact of implementing a comprehensive diabetes management program in managed care.
Diabetes mellitus places a significant burden on the U.S. healthcare system.
Because of the potential to reduce diabetic complications and costs through intensive management, diabetes has become a primary target for disease management programs.
We performed a retrospective analysis of short-term baseline and follow-up clinical, economic, and member and provider satisfaction data from approximately 7,000 people with diabetes being treated through seven managed care plans using Diabetes Treatment Centers of America's Diabetes NetCareSM, (Nashville, TN), a comprehensive diabetes management program.
Our analysis indicates that Diabetes NetCareSM achieved gross economic adjusted savings of$50 per diabetic member per month (12.3%), with gross unadjusted savings of $44 (10.9%) per diabetic member per month.
Hospital admissions per 1,000 diabetic member years decreased by 18%, and bed days fell by 21%. Patients with diabetes were more likely to get HbA1c tests, foot exams, eye exams, and cholesterol screenings while enrolled in the program.
These data suggest that implementation of a comprehensive healthcare management program for people with diabetes can lead to substantial improvements in costs and clinical outcomes in the short-term.
It is expected that improvements will increase over time, with continuing improvements in health status and a reduction in the number of future diabetic complications.
Mots-clés Pascal : Diabète, Soin intégré, Programme sanitaire, Etude économique, Exploration clinique, Analyse avantage coût, Complication, Prévention, Etats Unis, Amérique du Nord, Amérique, Homme, Endocrinopathie
Mots-clés Pascal anglais : Diabetes mellitus, Managed care, Sanitary program, Economic study, Clinical investigation, Cost benefit analysis, Complication, Prevention, United States, North America, America, Human, Endocrinopathy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0408779
Code Inist : 002B30A03B. Création : 25/01/1999.